Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly

Although the safety and efficacy of COVID-19 vaccines in older people are critical to their success, little is known about their immunogenicity among elderly residents of long-term care facilities (LTCFs). A single-center prospective cohort study was conducted: a total IgG antibody titer, neutralizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalla Gasperina, Daniela, Veronesi, Giovanni, Castelletti, Carlo M., Varchetta, Stefania, Ottolini, Sabrina, Mele, Dalila, Ferrari, Giuseppe, Shaik, Amruth K. B., Celesti, Fabrizio, Dentali, Francesco, Accolla, Roberto S., Forlani, Greta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530943/
https://www.ncbi.nlm.nih.gov/pubmed/37762029
http://dx.doi.org/10.3390/ijms241813728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530943/
https://www.ncbi.nlm.nih.gov/pubmed/37762029
http://dx.doi.org/10.3390/ijms241813728

Ejemplares similares